Vernal Biosciences highlighted in article by Pharma’s Almanac!
Vernal’s mRNA platform manufacturing capabilities have gotten the attention of the mRNA community. Read Pharma’s Almanac’s expose on Vernal here:…
News
Vernal’s growth plan going according to plan!
Seven Days wrote a great follow up article on Vernal’s growth since the summer of 2021. Click the link below…
Connect With Vernal’s Experts at the 10th International mRNA Health Conference!
Vernal is proud to be the Silver Sponsor for this exciting event! Connect with one of Vernal’s experts on November…
Construction begins on Vernal’s new mRNA manufacturing facility in Vermont!
Vernal Biosciences is excited to announce the start of construction on its new, 23,000 square foot mRNA manufacturing facility in…
Vernal Biosciences enters ‘mass hiring mode’ after raising $21 million in funding
Local NBC affiliate NBC5 came to visit Vernal Bioscience to discuss the eventual move to a new, larger facility in…
Vermont-based biotech startup raises $21 million in funding for mRNA production.
Vernal produces high-purity mRNA to supply to companies that develop mRNA-based health treatments. Read the full story at VTDigger.
Colchester’s Vernal Biosciences Raises $20 Million to Expand
Vernal Biosciences has received $21 million from investors and is expanding to a new laboratory in Essex next year.
Burlington tech startup raises millions to accelerate manufacturing growth
Vernal Biosciences has raised $21 million to build a manufacturing facility in Essex that will scale up the business from supporting research to being involved in clinical trials.
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
Vernal Biosciences announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solutions.
Vernal welcomes Scott Vanson and JJ Bivona to the team
We are excited to announce the addition of two new members to the Vernal team: Scott Vanson, Ph.D. and JJ Bivona, Ph.D.
Vernal Biosciences awarded nearly $100k in Vermont Training Grant
Vernal Biosciences has been awarded a $99,475 grant from the Vermont Training Program (VTP).
Vernal Biosciences launches preclinical LNP formulation service with biodistribution results
We recently completed a biodistribution study of lipid nanoparticles containing mRNA encoding luciferase in mice.